PXD074488 is an
original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Hierarchical small molecule inhibition of MYST acetyltransferases |
| Description | MYST lysine acetyltransferases (KATs) is a class of epigenetic enzymes critical for cellular function that constitute an emerging therapeutic target in cancer. Recently, several drug-like MYST inhibitors have been reported that show promise in a variety of preclinical models as well as in clinical trials of breast cancer. However, the comparative properties of these small molecules remain to be directly assessed. Here we apply an integrated profiling strategy to systematically define the potency and selectivity of drug-like MYST KAT inhibitors. First, we use optimized chemoproteomic profiling and histone acetylation biormarkers to study the industry-developed KAT inhibitor PF-9363. This revealed dose-dependent engagement of native KAT complexes, with hierarchical inhibition following the order KAT6A/B > KAT7 >> KAT8 > KAT5. Next, we demonstrate how PF-9363s ability to disrupt capture of MYST complex members in chemoproteomic experiments can be leveraged identify new candidate members of these complexes, including the transcription factor FOXK2. Applying insights from these studies to WM-8014, WM-1119 and WM-3835, which have been extensively applied in the literature as MYST probes, highlights unexpected cross-inhibition and suggests a new framework for how these small molecules and biomarkers may be applied to differentiate KAT6A/B and KAT7-dependent phenotypes. Finally, we benchmark the activity of PF-9363 in the NCI-60 cell line screen, providing evidence that its ability to inhibit the growth of cell lines that are resistant to other KAT inhibitors may derive from engagement of the essential KAT8 enzyme at high concentrations. Collectively, our studies indicate the potential for MYST KAT inhibitors to exhibit dose-dependent target engagement reminiscent of kinase inhibitors and specify assays and biomarkers for facile monitoring of selective and hierarchical effects. |
| HostingRepository | PRIDE |
| AnnounceDate | 2026-06-01 |
| AnnouncementXML | Submission_2026-05-31_16:08:26.773.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Kiall Francis Suazo |
| SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: NEWT:9606; |
| ModificationList | monohydroxylated residue; iodoacetamide derivatized residue |
| Instrument | LTQ Orbitrap Elite |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
| 0 | 2026-02-14 16:20:17 | ID requested | |
| ⏵ 1 | 2026-05-31 16:08:27 | announced | |
Publication List
| 10.1038/s41467-026-70574-1; |
| Chen X, Castroverde A, Perez M, Holewinski R, Suazo KF, Karki R, Andresson T, Garcia BA, Meier JL, Hierarchical small molecule inhibition of MYST acetyltransferases. Nat Commun, 17(1):(2026) [pubmed] |
Keyword List
| submitter keyword: histone acetylation,Lysine acetyltransferases, WM-1119, WM-3835, drug-like MYST inhibitors, chemoproteomics, MYST, FOXK2, PF-9363, WM-8014 |
Contact List
| Jordan Leslie Meier |
| contact affiliation | Chemical Biology Laboratory, National Cancer Institute |
| contact email | jordan.meier@nih.gov |
| lab head | |
| Kiall Francis Suazo |
| contact affiliation | Frederick National Laboratory |
| contact email | kiall.suazo@nih.gov |
| dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2026/06/PXD074488 |
| PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD074488
- Label: PRIDE project
- Name: Hierarchical small molecule inhibition of MYST acetyltransferases